| Maria Helena Nascimento De Lima, MD | |
|
2000 6th Ave S, Birmingham, AL 35233-2110 | |
| (205) 934-9999 | |
| Not Available |
| Full Name | Maria Helena Nascimento De Lima |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 21 Years |
| Location | 2000 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518212166 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
Agilent Technologies Inc. and BioTek Instruments, Inc., today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies.
Scientists from Harvard Medical School and MIT have designed a tattoo ink that can monitor a person's health by changing color to indicate dehydration or an increased blood sugar level, for example.
Merck, known as MSD outside the United States and Canada, and Endocyte Inc., today announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145).
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
Agilent Technologies Inc. and BioTek Instruments, Inc., today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies.
Scientists from Harvard Medical School and MIT have designed a tattoo ink that can monitor a person's health by changing color to indicate dehydration or an increased blood sugar level, for example.
Merck, known as MSD outside the United States and Canada, and Endocyte Inc., today announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Helena Nascimento De Lima, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: () - | Maria Helena Nascimento De Lima, MD 2000 6th Ave S, Birmingham, AL 35233-2110 Ph: (205) 934-9999 |
News Archive
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
Agilent Technologies Inc. and BioTek Instruments, Inc., today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies.
Scientists from Harvard Medical School and MIT have designed a tattoo ink that can monitor a person's health by changing color to indicate dehydration or an increased blood sugar level, for example.
Merck, known as MSD outside the United States and Canada, and Endocyte Inc., today announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145).
› Verified 8 days ago
Kamil Marcin Pietrasik, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-731-9701 | |
Dr. Maryam Saheb-al-zamani, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 510 20th St South, Birmingham, AL 35294 Phone: 205-934-2307 | |
Dr. Christopher Jon Schaffer, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 140 Village St Ste 100, Birmingham, AL 35242 Phone: 205-980-1744 Fax: 205-980-1334 | |
Dr. Michael S Clinton, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7191 Cahaba Valley Rd, Ste 200, Birmingham, AL 35242 Phone: 205-408-9787 Fax: 205-408-3993 | |
James Stephen Gunn, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Village St Ste 100, Birmingham, AL 35242 Phone: 205-980-1744 Fax: 205-980-1334 | |
Guillermo Oswaldo Ramos-gallardo, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-731-9701 Fax: 205-297-9411 | |
Dr. William B Nickell, M,D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 Cahaba Park Cir, Birmingham, AL 35242 Phone: 295-980-9393 Fax: 205-980-4494 |